BN
Therapeutic Areas
AngioInsight Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AngioAI+™ Platform | Diagnosis and management of Coronary Artery Disease (CAD) and Coronary Microvascular Disease (CMD) | Investigational |
Leadership Team at AngioInsight
SB
Scott Burger
Chief Executive Officer
VP
Vas Paruchuri, PhD
Chief Technical Officer
TV
Todd Villines, MD
Chief Medical Officer
BR
Bill Revelos, ESQ
Legal Counsel
AF
Alberto Figueroa, PhD
Co-Founder, Chief Science Officer
GZ
Gabrielle Zaeska
SVP, Regulatory Affairs and Quality